home / stock / viri / viri news

VIRI News and Press, Virios Therapeutics Inc.

Stock Information
Company Name: Virios Therapeutics Inc.
Stock Symbol: VIRI
Market: NASDAQ
Website: virios.com
Menu
VIRI VIRI Quote VIRI Short VIRI News VIRI Articles VIRI Message Board
Get VIRI Alerts

News, Short Squeeze, Breakout and More Instantly...
VIRI - Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

ATLANTA, May 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibro...
VIRI - US Companies Moving the Markets, Evening edition
Mon, May 20, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 16.4% to $0.199 on volume of 720,586,242 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 74.8% to $1.8 on volume of 682,362,254 shares Pineapple Energy Inc. (PEGY) rose 80.3% to $0.1...

VIRI - US Companies Moving the Markets, Morning edition
Mon, May 20, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 37.1% to $0.2344 on volume of 300,511,226 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 78.2% to $1.835 on volume of 218,102,513 shares Greenwave Technology Solutions Inc. (GWAV) r...

VIRI - Virios Therapeutics shares slid on pricing public offering of units to raise $1.7M

2024-05-20 03:48:07 ET More on Virios Therapeutics Virios Therapeutics announces proposed public offering of common stock Seeking Alpha’s Quant Rating on Virios Therapeutics Historical earnings data for Virios Therapeutics Financial information for Vir...
VIRI - Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

ATLANTA, May 19, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibro...

VIRI - Virios Therapeutics announces proposed public offering of common stock

2024-05-17 16:21:24 ET More on Virios Therapeutics Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Virios Therapeutics Historical earnings data for Virios Therapeutics Financial information for Virios T...

VIRI - Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study

ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibro...
VIRI - Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Call Transcript

2024-05-11 23:44:08 ET Virios Therapeutics, Inc. (VIRI) Q1 2024 Earnings Conference Call May 09, 2024 08:30 am ET Company Participants Angela Walsh - Senior Vice President of Finance, Secretary & Treasurer Greg Duncan - Chief Executive Officer & Chairman of t...

VIRI - Virios Therapeutics GAAP EPS of -$0.07 misses by $0.03

2024-05-09 08:16:50 ET More on Virios Therapeutics Seeking Alpha’s Quant Rating on Virios Therapeutics Historical earnings data for Virios Therapeutics Financial information for Virios Therapeutics Read the full article on Seeking Alpha For fur...

VIRI - Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

- Top-line results from the ongoing investigator-initiated Bateman Horne Center Long-COVID phase 2 featuring valacyclovir and celecoxib (IMC-2) expected in the second-half of 2024 - - Conference Call Today at 8:30 a.m. ET - ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Virios Therap...
Next 10